Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
52%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
44%
ALSO IN PBPH
PBPH
56
HOLDINGS
24%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PBPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PBPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 15.5% | 15.5% |
|
ABBVIE INC | 10.3% | 7.2% | 7.2% |
|
JOHNSON & JOHNSON | 6.1% | 10.0% | 6.1% |
|
MERCK & CO. INC. | 4.7% | 5.7% | 4.7% |
 |
ASTRAZENECA PLC | 4.5% | 4.7% | 4.5% |
MEDX Overweight Relative to PBPH
 |
NOVARTIS AG-ADR | 6.7% |
 |
ALKERMES PLC | 4.5% |
|
ELI LILLY & CO | 3.7% |
|
ABBVIE INC | 3.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% |
|
CRISPR THERAPEUTICS AG | 2.7% |
|
BIOGEN IDEC INC | 2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.1% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% |
MEDX Underweight Relative to PBPH
|
NOVARTIS AG | -4.2% |
|
GILEAD SCIENCES INC | -4.0% |
|
JOHNSON & JOHNSON | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -2.8% |
 |
NOVO NORDISK A/S-B | -2.6% |
|
GSK PLC | -2.0% |
 |
SANOFI-AVENTIS | -1.9% |
|
MODERNA, INC. | -1.5% |
 |
CSL LIMITED | -1.3% |
 |
ARGEN-X SE | -1.3% |